| PC | Prostate cancer |
| mCRPC | Metastatic castration-resistant prostate cancer |
| ADT | Androgen deprivation therapy |
| ARSI | Androgen receptor signaling inhibitor |
| PARPi | PAR inhibitor |
| HRR | Homologous recombination repair |
| PFS | Progression-free survival |
| OS | Overall survival |
| CDX | Cell-derived xenograft |
| PSA | Prostate-specific antigen |
| AR | Androgen receptor |
| NEPC | Neuroendocrine prostate cancer |
| DDR | DNA damage response |